Epilepsy Research
Volume 30, Issue 3 , Pages 231-240 , May 1998

The relationship between seizure frequency, seizure type and quality of life: Findings from three European countries

  • Gus A Baker

      Affiliations

    • University Department of Neurosciences, Walton Centre for Neurology and Neurosurgery, Rice Lane, Liverpool, L9 1AE, UK
    • Corresponding Author InformationCorresponding author. Fax: +44 151 5294703; e-mail: baker-g@wcnn.co.uk
    • ,
  • Dennis Gagnon

      Affiliations

    • ICOM Health Economics, Johnson and Johnson, Raritan, New Jersey, USA
    • ,
  • Pauline McNulty

      Affiliations

    • ICOM Health Economics, Johnson and Johnson, Raritan, New Jersey, USA

Received 10 October 1997 ,Revised 11 February 1998 ,Accepted 15 February 1998.

References 

  1. Baker GA, Smith DF, Dewey M, Jacoby A, Chadwick DW. The initial development of a health-related quality of life model as an outcome measure in epilepsy. Epilepsy Res. 1993;16:65–81
  2. Baker GA, Nashef L, Van Hout B. Current issues in the management of epilepsy: The impact of frequent seizures on cost of illness, quality of life and mortality. Epilepsia. 1997;38(Suppl. 1):S1–8
  3. Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: A European study. Epilepsia. 1997;38:353–362
  4. Collings J. Psychosocial well-being and epilepsy: An empirical study. Epilepsia. 1990;31:418–426
  5. Dodrill CB, Beier R, Kasparick M, Tacke I, Tacke U, Tan SY. Psychosocial problems in adults with epilepsy: Comparison of findings from four countries. Epilepsia. 1984;25(2):176–183
  6. Dodrill CB, Arnett JL, Sommerville KW, Shu V. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy. Neurology. 1997;48:1025–1031
  7. Fallowfield, L., 1994. An overview of quality of life measurements. In: Trimble, M.R. and Dodson, W.E. (Eds.), Epilepsy and Quality of Life. Raven Press, New York, pp. 183–197.
  8. Jacoby A, Baker GA, Smith D, Dewey M, Chadwick DW. Measuring the impact of epilepsy: The development of a novel scale. Epilepsy Res. 1993;16:83–88
  9. Jacoby A, Baker GA, Steen N, Potts P, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: Findings from a UK community study. Epilepsia. 1996;37(2):148–161
  10. Jette AM, Davies AR, Cleary PD, Calkins DR, Rubenstein LV, Fink A, et al. The Functional Status Questionnaire: Reliability and validity when used in primary care. J. Gen. Intern. Med. 1986;1:143–149
  11. Shofer JB, Temkin NR. Comparison of alternative outcome measures of antiepileptic drug trials. Arch. Neurol. 1986;43:877–881
  12. Smith DF, Baker GA, Dewey M, et al.  Seizure frequency, patient perceived seizure severity and the psychosocial consequences of intractable epilepsy. Epilepsy Res. 1991;9:231–241
  13. Smith DF, Baker GA, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia. 1993;34(2):312–322
  14. Van Belle, G. and Temkin, N.R., 1981. Design strategies in the clinical evaluation of new antiepileptic drugs. In: Pedley, T.A. and Meldrum, B.S. (Eds.), Recent Advances in Epilepsy. Churchill Livingstone, Edinburgh, 1981, pp. 93–111.
  15. Van Hout B, Gagnon D, Souetre E, Reid S, Remy C, Baker GA, et al. Effects of seizure frequency on costs and quality of life of outpatients with partial epilepsy in France, Germany and the United Kingdom. Epilepsia. 1997;38(11):1221–1226
  16. Ware JE, Sherbourne CD. The MOS 36-item Short-form health survey (SF36) 1. Conceptual framework and item selection. Med. Care. 1992;30(6):473–483

PII: S0920-1211(98)00010-2

Epilepsy Research
Volume 30, Issue 3 , Pages 231-240 , May 1998

Article Tools

* Image Usage & Resolution